Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Revenue (2021 - 2025)

Biote has reported Revenue over the past 5 years, most recently at $46.4 million for Q4 2025.

  • Quarterly results put Revenue at $46.4 million for Q4 2025, down 6.87% from a year ago — trailing twelve months through Dec 2025 was $192.2 million (down 2.52% YoY), and the annual figure for FY2025 was $192.2 million, down 2.52%.
  • Revenue for Q4 2025 was $46.4 million at Biote, down from $48.0 million in the prior quarter.
  • Over the last five years, Revenue for BTMD hit a ceiling of $51.4 million in Q3 2024 and a floor of $34.8 million in Q2 2021.
  • Median Revenue over the past 5 years was $45.7 million (2023), compared with a mean of $44.6 million.
  • Biggest five-year swings in Revenue: rose 20.73% in 2023 and later dropped 6.87% in 2025.
  • Biote's Revenue stood at $37.5 million in 2021, then increased by 18.51% to $44.5 million in 2022, then grew by 2.74% to $45.7 million in 2023, then grew by 9.04% to $49.8 million in 2024, then dropped by 6.87% to $46.4 million in 2025.
  • The last three reported values for Revenue were $46.4 million (Q4 2025), $48.0 million (Q3 2025), and $48.9 million (Q2 2025) per Business Quant data.